When to modify or discontinue peptide therapy Continue indicators: Stable disease vs historical progression, measurable improvements in objective testing, good tolerability without significant side effects, financial sustainability, patient satisfaction with outcomes
Subsequently summarized in: Pickart L, Margolina A
If you want to understand where a specific peptide stands, start with the regulatory tracker or the BPC-157 overview
Free Worldwide Shipping Secure Payment Process Competitive Bulk Pricing Reliable Batch Consistency Description GHK-Cu is a copper-binding peptide commonly studied in relation to skin-support pathways, collagen signalling, cellular repair, and tissue-remodelling
During the HMs-induced ROS scavenging system the GSH is changed to its oxidized form (GSSG) which is one of the key processes of the redox signaling process (Figure 3)
Dissipates quickly after application